---
title: "Lepu Medical: Subsidiary's injectable cross-linked sodium hyaluronate gel has received NMPA registration approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254454981.md"
description: "Lepu Medical's subsidiary Sichuan Xingtai Pule Medical Technology Co., Ltd. has received registration approval from the National Medical Products Administration for its injectable cross-linked sodium hyaluronate gel. This product is intended for injection in the nasolabial fold area of the face, aiming to correct moderate to severe wrinkles. This approval will enrich the company's product line in the dermatology field and is expected to have a positive impact on the company's development, but the sales performance of the new product and future results remain uncertain"
datetime: "2025-08-25T12:59:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254454981.md)
  - [en](https://longbridge.com/en/news/254454981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254454981.md)
generator: "portal-rs"
---

# Lepu Medical: Subsidiary's injectable cross-linked sodium hyaluronate gel has received NMPA registration approval

Lepu Medical announced that its subsidiary Sichuan Xingtai Pule Medical Technology Co., Ltd. has independently developed an injectable cross-linked sodium hyaluronate gel that has received registration approval from the National Medical Products Administration. This product is suitable for injection into the mid to deep dermal tissue of the facial nasolabial fold area to correct moderate to severe nasolabial fold wrinkles. The approval of this product further enriches the company's product matrix in the dermatology field and is expected to have a positive impact on the company's development. However, the specific sales situation of the new product after its launch may be affected by various factors, and the impact on the company's future performance is uncertain

### Related Stocks

- [300003.CN](https://longbridge.com/en/quote/300003.CN.md)

## Related News & Research

- [Jiangsu Yuyue Medical Equipment & Supply: Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply](https://longbridge.com/en/news/296602713.md)
- [Delphinus backs NorFalk financing round, taking funding past EUR 5 million](https://longbridge.com/en/news/296751333.md)
- [Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows](https://longbridge.com/en/news/296603687.md)
- [Nexstim receives NBS 6 system order from European hospital customer](https://longbridge.com/en/news/296574081.md)
- [09:04 ETTransformativeMed Partners with Red Rover Health to Bring Agentic AI Across Clinical Workflows](https://longbridge.com/en/news/296622164.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**